← Back to Clinical Trials
Recruiting NCT07238803

NCT07238803 Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07238803
Status Recruiting
Phase
Sponsor Zagazig University
Condition Kidney Stone
Study Type INTERVENTIONAL
Enrollment 33 participants
Start Date 2024-12-01
Primary Completion 2025-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
flexible and navigable suction sheath with flexible ureteroscopy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 33 participants in total. It began in 2024-12-01 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to evaluate and assess the outcomes of flexible ureteroscopy (FURS) with flexible and navigable suction UAS (FANS) in the treatment of lower calyceal stones.

Eligibility Criteria

Inclusion Criteria: 1. Adult patients ≥ 18 years old. 2. Patients with lower calyceal stones scheduled for FURS. Exclusion Criteria: 1. patients with active urinary tract infections. 2. Patients with renal and ureteric anomalies. 3. patients with coagulopathy 4. patients who are refusing to participate.

Contact & Investigator

Central Contact

Mahmoud Ahmed Lasheen, Resident

✉ ma.ahmed24@fakmed.zu.edu.eg

📞 +201069524468

Principal Investigator

Abdul Latif Mohammed Zayed, professor of urology

STUDY DIRECTOR

Zagazig University

Frequently Asked Questions

Who can join the NCT07238803 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Stone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07238803 currently recruiting?

Yes, NCT07238803 is actively recruiting participants. Contact the research team at ma.ahmed24@fakmed.zu.edu.eg for enrollment information.

Where is the NCT07238803 trial being conducted?

This trial is being conducted at Zagazig, Egypt.

Who is sponsoring the NCT07238803 clinical trial?

NCT07238803 is sponsored by Zagazig University. The principal investigator is Abdul Latif Mohammed Zayed, professor of urology at Zagazig University. The trial plans to enroll 33 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology